OCULUS INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c23ac982-76a1-4078-b4b3-17e715b8308a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-319.1k | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-009176 |
| FY 2024 | $-327.4k | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-008527 |
| FY 2023 | $-591.2k | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-008443 |
| FY 2022 | $-1.6M | 2022-01-01 – 2022-12-31 | evidence 0001437749-23-008107 |
| FY 2021 | $-2.0M | 2021-01-01 – 2021-12-31 | evidence 0001437749-22-006790 |
| FY 2020 | $-2.8M | 2020-01-01 – 2020-12-31 | evidence 0001437749-21-006065 |
| FY 2019 | $-192.9k | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-004714 |
| FY 2018 | $-183.3k | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-006007 |
| FY 2017 | $-230.7k | 2017-01-01 – 2017-12-31 | evidence 0001437749-18-005840 |
| FY 2016 | $-453.2k | 2016-01-01 – 2016-12-31 | evidence 0001437749-17-005714 |
| FY 2015 | $-386.6k | 2015-01-01 – 2015-12-31 | evidence 0001575872-16-000314 |
| FY 2014 | $-260.3k | 2014-01-01 – 2014-12-31 | evidence 0001575872-16-000314 |
| FY 2013 | $93.6k | 2013-01-01 – 2013-12-31 | evidence 0001273511-14-000040 |
| FY 2012 | $339.2k | 2012-01-01 – 2012-12-31 | evidence 0001273511-14-000040 |
| FY 2011 | $-161.6k | 2011-01-01 – 2011-12-31 | evidence 0001273511-12-000029 |
| FY 2010 | $-89.2k | 2010-01-01 – 2010-12-31 | evidence 0001273511-12-000029 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).